Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.405 USD | +0.15% | -1.02% | +255.53% |
Capitalization | 1.7B 1.62B 1.51B 1.35B 2.4B 144B 2.63B 18.77B 6.96B 59.18B 6.4B 6.26B 255B | P/E ratio 2024 * |
-28.8x | P/E ratio 2025 * | -24.7x |
---|---|---|---|---|---|
Enterprise value | 1.45B 1.38B 1.29B 1.15B 2.05B 123B 2.25B 16.02B 5.94B 50.52B 5.46B 5.34B 217B | EV / Sales 2024 * |
1.05x | EV / Sales 2025 * | 0.89x |
Free-Float |
75.33% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Clover Health Investments, Corp.
1 day | -0.87% | ||
Current month | -2.30% | ||
1 month | -19.05% | ||
3 months | +36.00% | ||
6 months | +190.60% | ||
Current year | +257.11% |
Director | Title | Age | Since |
---|---|---|---|
Andrew Toy
CEO | Chief Executive Officer | 45 | 2022-12-31 |
Peter Kuipers
DFI | Director of Finance/CFO | 52 | 2024-05-06 |
Conrad Wai
CTO | Chief Tech/Sci/R&D Officer | 43 | 2022-02-27 |
Manager | Title | Age | Since |
---|---|---|---|
Vivek Garipalli
CHM | Chairman | 45 | 2022-12-31 |
Lee Shapiro
BRD | Director/Board Member | 68 | 2021-01-06 |
Andrew Toy
BRD | Director/Board Member | 45 | 2018-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 287 M€ | +21.46% | - | |
0.01% | 9 M€ | -.--% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.87% | 0.00% | +257.89% | -20.93% | 1.7B | ||
-0.54% | -0.26% | +10.61% | +34.70% | 557B | ||
-0.57% | +1.52% | -15.53% | +3.31% | 94.64B | ||
-0.64% | -0.03% | +24.49% | +67.57% | 93.15B | ||
-0.68% | -1.51% | -41.21% | -30.96% | 35.06B | ||
-1.08% | -0.98% | -20.66% | -16.38% | 29.99B | ||
+3.32% | +5.07% | -14.02% | +9.08% | 17.84B | ||
-2.26% | +2.28% | +70.52% | -14.33% | 2.41B | ||
-4.75% | -2.75% | -57.07% | -68.89% | 1.26B | ||
-0.12% | +0.07% | - | - | 488M | ||
Average | -0.82% | +0.71% | +23.89% | -4.09% | 83.35B | |
Weighted average by Cap. | -0.51% | +0.48% | +5.94% | +29.24% |
2024 * | 2025 * | |
---|---|---|
Net sales | 1.38B 1.31B 1.22B 1.09B 1.94B 117B 2.13B 15.23B 5.65B 48.01B 5.19B 5.08B 207B | 1.61B 1.54B 1.43B 1.27B 2.27B 137B 2.49B 17.78B 6.59B 56.06B 6.06B 5.93B 241B |
Net income | -59.62M -56.72M -52.83M -47.09M -83.88M -5.05B -92.08M -657M -244M -2.07B -224M -219M -8.92B | -56.31M -53.57M -49.9M -44.48M -79.21M -4.77B -86.96M -620M -230M -1.96B -212M -207M -8.42B |
Net Debt | -249M -237M -221M -197M -351M -21.13B -385M -2.75B -1.02B -8.66B -937M -916M -37.29B | -270M -257M -239M -213M -380M -22.87B -417M -2.97B -1.1B -9.38B -1.01B -992M -40.37B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-04 | 3.395 $ | -0.15% | 2,001,932 |
24-12-03 | 3.400 $ | -0.87% | 3,415,299 |
24-12-02 | 3.430 $ | -1.44% | 6,538,694 |
24-11-29 | 3.480 $ | +1.75% | 3,077,053 |
24-11-27 | 3.420 $ | +0.59% | 3,663,651 |
Delayed Quote Nasdaq, December 03, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- CLOV Stock